Archives

by in
Entry Author Date Location
Biogen Reports 10th PML Case in Tysabri Patient 06/29/09 Boston
Biogen Idec Showdown with Carl Icahn Culminates in Shareholder Vote Today 06/03/09 Boston
Icahn’s Plan to Split Up Biogen Idec Would “Destroy Shareholder Value,” Company Says 05/15/09 Boston
Avila Therapeutics Hires First CEO Katrine Bosley, Adds $5M from Existing Investors 05/15/09 Boston
Biogen Idec Pipeline Strong, Tysabri Coming Back; Icahn Would “Weaken” Board, Company Says 05/14/09 Boston
Taligen Raises $26M For Inflammation Drugs 05/12/09 Boston
Icahn Throws Down the Gauntlet, Attacks Biogen Idec’s “Failed Leadership” 05/11/09 Boston
Tysabri May Promote Healing Around Nerves, Study Says 04/28/09 Boston
Biogen Idec To Show Off MS Drugs at Seattle Neurology Meeting 04/24/09 Boston
Biogen Idec Tysabri Sales Fall Shy of Street Expectations 04/16/09 Boston
FDA Allows High-Yield Tysabri Production 04/16/09 Boston
Rematch Time: Carl Icahn and Biogen Idec Square Off Again 04/14/09 Boston
Carl Icahn Aims to Stick “For Sale” Sign on Biogen Idec Lawn Again 02/06/09 Boston
Biogen Idec Rival Succeeds in Trial of Oral Pill for Multiple Sclerosis 01/23/09 Boston
Seattle’s Top 10 Innovation Stories of the Half-Year (and Others We Just Plain Liked) 12/31/08 Seattle
New RNAi Drugs, Major Cutbacks at Targanta, Big Partnerships for Arqule and Archemix, & More Boston-Area Life Sciences News 12/24/08 Boston
Tysabri Patient Dies of Brain Infection, First Death Since Drug Re-Introduced 12/19/08 Boston
Tysabri Patient Diagnosed With PML 12/15/08 Boston
Biogen Idec VC Group Sees Opportunity in Tough Market, Has $100M New Allocation to Invest in Biotech Firms 12/12/08 San Diego
Tysabri’s Roots at the “Hutch,” MediQuest Spurned by FDA, ZymoGenetics Drug Passes Test, & More Seattle-Area Life Sciences News 11/06/08 Seattle
A Trio of Tysabri Stories, Genzyme’s Big Deal with Osiris, A Peek Inside a Winning Hedge Fund, & More Life Sciences News 11/05/08 Boston
Tysabri: The Big Multiple Sclerosis Drug That Emerged From “The Hutch” 11/04/08 Seattle
Democratic Party Fundraiser Dies, After Friends and Family Pushed To Get Him Tysabri 10/31/08 Boston
Biogen Idec, Elan’s Tysabri Linked to First U.S. Case of Brain Infection 10/29/08 Boston
Dying Cancer Patient Gets Tysabri After Biogen Idec’s Earlier Denial 10/16/08 Boston
Biogen Turns Down Dying Patient’s Request For Tysabri—and Explains Why 10/14/08 Boston
Biogen Idec, Elan Start First Cancer Trial With Tysabri 09/05/08 Boston
Biogen Idec Testing Regenerative Medicine Drug to Reverse the Path of Multiple Sclerosis 08/27/08 Boston
FDA Doesn’t Appear Overly Alarmed by Recent Cases of Brain Disease Associated With Tysabri; Working with Biogen Idec and Elan to Update Labeling 08/26/08 Boston
Taligen CEO Aims to Develop Drugs For Inflammatory Diseases, Build Company in Cambridge 08/14/08 Boston
Page 2 of 3 « previous page · next page »

Xconomy Events Across the Network

The Napa Summit 2013: New Rules for Growth

San Francisco · 6/3/13

More Xconomy Events

Xconomy’s Most Popular

  1. Henri Termeer on Startups, Drug Prices, Getting Older (Part 1)
  2. Nine Lessons for Innovators from a Nobel Prize-Winning Psychologist
  3. Xconomy Opens in Texas, Expanding Roundup of Innovation Across U.S.
  4. Zillions of Biotech Conferences Want You. Which Should You Attend?
  5. Life After PowerPoint: Prezi Zooms Ahead in Digital Storytelling

Xconomy on Demand

Did you miss something? Don't despair…

Xconomy offers a number of ways to subscribe for free!

Subscribe Now
IDG Tech Network
Protected by Mozy
Eventbrite - events made easy

Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit, San Francisco, New York, Boulder/Denver, Texas and beyond.

© 2007-2013, Xconomy, Inc. Xconomy is a registered service mark of Xconomy, Inc. All rights reserved.

Website development support from Andrew Koyfman with design support from Rob Hunter.